• Search
  • Helpdesk
  • Sales contact

Resources

Explore our latest insights in clinical trials, delve into new trends in eCOA and ePRO trials, understand therapeutic area-specific challenges, discover recent innovations and technologies enhancing user experience and data quality, and much more to empower your studies.

  • Patient voice
  • Therapeutic areas
  • Expert Channel
  • Operational excellence
  • Kayentis solution
  • Kayentis spirit
  • Events
Filter:

Patient voice

See all

Working with patient associations: What is the key to a positive interaction?

What rare disease patients and families want is a simpler life.Discover here what makes the relationship between the members of the patients’ association and a company work so well.https://www.youtube.com/watch?v=R65yKqxo4zQ Check...

How a patient association gave rise to a company

A patient association in rare diseases is first and foremost families who all have one thing in common: they need...

Direct insights from cancer patients: How they help us understand disease burden and the need for an individualized approach

Cultural differences and individual preferences have a significant impact on healthcare and clinical trial experience. Solutions exist in attempt to...

Working in collaboration with patient associations: insights from Estelle Haenel, Kayentis Medical Director

Whilst we hear a lot about working in collaboration with patient representatives, not so many industrial stakeholders are actually doing...

Therapeutic areas

See all

Rare disease clinical research: it is time to tackle what matters most to patients

Supporting the development and evaluation of new treatments for rare diseases has become a key priority of the 21st century. Over 7,000 distinct rare diseases, affecting around 36 million people...

Rethinking pediatric clinical trials: guidelines from pediatric experts

In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Overcoming challenges in long-lasting pediatric clinical trials – Insights from site experts

In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s...

Tackling the specificities of NASH/MASH clinical trials

Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating chronic illness that significantly impairs...

Expert channel

See all

Rethinking pediatric clinical trials: guidelines from pediatric experts

In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement lead at SJD Barcelona Children’s Hospital (Spain), and Vivienne Van de Walle, pediatrician and Director/Research...

Operational excellence

See all

The strengths of electronic Clinical Outcome Assessment (eCOA) versus paper solutions

In contrast to paper solutions, electronic Clinical Outcome Assessment (eCOA) demonstrates strengths such as:AccuracyCompletenessTimingsAttributabilityUser-friendlinessRegulatory compliance Download the "eCOA vs paper" infographic Ask for a demo

The relevance of ePROs in early phase clinical trials

Early phase clinical research (phase 1 and 2a) focuses on characterizing the behavior of the investigational product in humans, finding...

3 considerations to take into account when setting up an eCOA clinical trial

In a clinical trials environment that is moving increasingly towards digitalization and decentralization, it remains crucial to maintain high-quality electronic...

Kayentis operational excellence

Why do customers recommend Kayentis for operational excellence? More than 95% of Kayentis customers recommend Kayentis for its: Customer-centric approach...

Kayentis solution

See all

Biotech and eCOA vendor: A shared mindset

Biotechs play a pivotal role in driving innovation, contributing significantly to the development of groundbreaking therapies for patients. But they are operating under tremendous pressure due to time and cost...

Kayentis operational excellence

Why do customers recommend Kayentis for operational excellence? More than 95% of Kayentis customers recommend Kayentis for its: Customer-centric approach...

Why you should implement a BYOD strategy for your eCOA trial

Improve your clinical trial efficiency and offer more choice to patients by implementing a BYOD strategy for your eCOA trial!...

3 tips to support successful BYOD decision-making for your eCOA trial 

Bring Your Own Device (BYOD) and Provisioned Device (PD) methods will generally work for any eCOA study, but there are...

Kayentis spirit

See all

The client’s voice: why they consistently choose Kayentis

At Kayentis, client satisfaction isn't just a goal—it's our standard. We pride ourselves on delivering services that embody responsiveness, reliability, professionalism, friendliness, and excellence. The essence of what we provide...

Why you should join Kayentis

At Kayentis, we value each individual and we form a community that goes beyond the sum of individuals. Our company’s...

Kayentis 2023 Gender Equality Index

In accordance with the provisions of the French "Professional Future" law of September 5, 2018, Kayentis has established its Gender...

Kayentis raises further €5M to boost US activities

Additional funds will be used to scale-up Kayentis’ operations in North America to support clinical trials Grenoble, France, March 28,...

Events

See all

Mobile in Clinical Trials

16 SEPT 2024 • Philadelphia, USA
https://mobileinclinicaltrials.com/

DPharm 2024

17-18 SEPT 2024 • Philadelphia, USA
https://dpharmconference.com/   

SCDM 2024

29 SEPT - 2 OCT 2024 • Boston, USA
https://scdmlive.org/annual-conference-2024/